Literature DB >> 16439725

A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke.

C-C Lai1, C-J Hu.   

Abstract

An 81 year old man with a history of hypertension received intravenous recombinant tissue plasminogen activator (tPA) for right middle cerebral artery (MCA) infarction. He had not had stroke or arrhythmia previously. The initial National Institute of Health Stroke Scale (NIHSS) score was 8. However, a left MCA territory infarction developed 2 minutes after the full course of tPA therapy was completed, and 24 hours after tPA infusion, NIHSS score was 17. The subsequent magnetic resonance imaging scan confirmed an extensive left MCA territory infarction and a small right MCA territory infarction. Although the intracerebral haemorrhage after tPA therapy is relatively more common, tPA infusion may result in an ischaemic cerebral stroke in rare cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439725      PMCID: PMC2564067          DOI: 10.1136/emj.2004.022681

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  8 in total

1.  Ischemic stroke. Impact of a recent myocardial infarction.

Authors:  T Mooe; B O Olofsson; B Stegmayr; P Eriksson
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

Authors:  G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

3.  An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction.

Authors:  G Y Chang
Journal:  Eur J Neurol       Date:  2001-05       Impact factor: 6.089

4.  Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.

Authors:  Andrei V Alexandrov; James C Grotta
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Comparison of neurological scales and scoring systems for acute stroke prognosis.

Authors:  K W Muir; C J Weir; G D Murray; C Povey; K R Lees
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

7.  Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.

Authors:  Susanne Schmülling; Jobst Rudolf; Timm Strotmann-Tack; Martin Grond; Susanne Schneweis; Jan Sobesky; Alexander Thiel; Wolf-Dieter Heiss
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

8.  Putaminal haemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator.

Authors:  H Brückmann; A Ferbert
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

  8 in total
  2 in total

1.  Treating Triple Thrombus-Pulmonary, Cardiac, and Cerebral: A Case Management with Calculated Conscience.

Authors:  Ashok V R Taallapalli; Mahammad S Mondal; Reshma S Shaik; P R Srijithesh; Girish B Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2021-04-05       Impact factor: 1.383

2.  Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case.

Authors:  Akira Sugie; Makoto Yamada; Kunio Yokoyama; Tomoaki Miyake; Yutaka Ito; Hidekazu Tanaka; Yukiya Nomura; Masutsugu Fujita; Toshio Nakatani; Masahiro Kawanishi
Journal:  J Neurosurg Case Lessons       Date:  2021-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.